An analysis of the prognostic significance of p53 status for squamous cell carcinoma of the oral cavity treated by radiotherapy

Oral Oncology

Volumn 34, Issue 6, 1998, Pages 513-518

  Hiranuma, H ^a   Jikko, A ^a   Maeda, T ^a   Matumura, S ^a   Murakami, S ^a   Fukuda, Y ^a   Furukawa, S ^a   Ishida, T ^a   Fuchihata, H ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Carcinoma; Oral; p53; Prognosis; Radiotherapy; Squamous cell

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; MALE; MOUTH CARCINOMA; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS;

EID: 0031732236     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00058-X     Document Type: Article

References (30)

1. Parkin D. M., Muir C. S. Cancer incidence in five continents. Comparability and quality of data. IARC Scientific Publications 1992:45-173.
2. Brock W. A., Baker F. L., Wike J. L., Sivon S. L., Peters L. J. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. International Journal of Radiation Oncology, Biology, Physics. 18:1990;1283-1286.
3. Hendry J. H., West C. M. Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation response. International Journal of Radiation Biology. 71:1997;709-719.
4. Levine A. J., Momand J., Finlay C. A. The p53 tumour suppressor gene. Nature. 351:1991;453-456.
5. Sakai E., Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene. 7:1992;927-933.
6. Boyle J. O., Hakim J., Koch W., et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Research. 53:1993;4477-4480.
7. Smith M. L., Chen I. T., Zhan Q., O'Connor P. M., Fornace Jr A. J. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene. 10:1995;1053-1059.
8. Kuerbitz S. J., Plunkett B. S., Walsh W. V., Kastan M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of the National Academy of Sciences, USA. 89:1992;7491-7495.
9. Lowe S. W., Schmitt E. M., Smith S. W., Osborne B. A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
10. Pardo F. S., Su M., Borek C., et al. Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiation Research. 140:1994;180-185.
11. Lee J. M., Bernstein A. p53 mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences, USA. 90:1993;5742-5746.
12. Bristow R. G., Benchimol S., Hill R. P. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiotherapy and Oncology. 40:1996;197-223.
13. Greenblatt M. S., Bennett W. P., Hollstein M., Harris C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research. 54:1994;4855-4878.
14. Awwad S., Jaros E., Somes J., Lunec J. P53 overexpression in head and neck carcinoma and radiotherapy results. International Journal of Radiation Oncology, Biology, Physics. 34:1996;323-332.
15. Pekkola-Heino K., Servomaa K., Kiuru A., Grenman R. Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma. Acta Otolaryngologia (Oslo). 116:1996;341-344.
16. Bundgaard T., Bentzen S. M., Wildt J., Sorensen F. B., Sogaard H., Nielsen J. E. Histopathologic, stereologic, epidemiologic, and clinical parameters in the prognostic evaluation of squamous cell carcinoma of the oral cavity. Head and Neck. 18:1996;142-152.
17. Wilson G. D., Richman P. I., Dische S., et al. p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy. British Journal of Cancer. 71:1995;1248-1252.
18. Condie A., Eeles R., Borresen A. L., Coles C., Cooper C., Prosser J. Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Human Mutation. 2:1993;58-66.
19. Rabbitts T. H. Chromosomal translocations in human cancer. Nature. 372:1994;143-149.
20. Kasid U., Pfeifer A., Weichselbaum R. R., Dritschilo A., Mark G. E. The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science. 237:1987;1039-1041.
21. Sklar M. D. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science. 239:1988;645-647.
22. Sigalas I., Calvert A. H., Anderson J. J., Neal D. E., Lunec J. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nature Medicine. 2:1996;912-917.
23. Tanaka N., Ishihara M., Lamphier M. S., et al. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature. 382:1996;816-818.
24. Tsang N. M., Nagasawa H., Li C., Little J. B. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene. 10:1995;2403-2408.
25. Thomas J. A., Allday M. J., Crawford D. H. Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals. Advances in Cancer Research. 57:1991;329-380.
26. Strasser A., Harris A. W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:1994;329-339.
27. Henderson S., Rowe M., Gregory C., et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 65:1991;1107-1115.
28. Brachman D. G., Graves D., Vokes E., et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Research. 52:1992;4832-4836.
29. Maeda T., Hiranuma H., Matsumura S., Furukawa S., Fuchihata H. Epstein-Barr virus infection and tumor response to radiotherapy in squamous cell carcinoma of the oral cavity. Cancer Letters 1998;125:25-30.
30. Chang E. H., Jang Y. J., Hao Z., et al. Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy. Archives of Otolaryngology-Head and Neck Surgery. 123:1997;507-512.